Contact information
michael.desborough@linacre.ox.ac.uk
michael.desborough@ouh.nhs.uk
Department of Clinical Haematology, Churchill Hospital, Oxford, OX3 9DU
He/Him
Research groups
Colleges
Michael Desborough
BMedSci(Hons), MB ChB, FRCP, FRCPath, DPhil
Consultant Haematologist & Associate Professor of Haematology
The overarching aim of the research conducted by my group is to develop and trial new treatments for platelet disorders and finding alternatives to platelet transfusion.
- This includes trials of reversing antiplatelet drugs in intracerebral haemorrhage
- Optimising treatment of fetal and neonatal alloimmune thrombocytopenia (FNAIT)
- Clinical trials in transfusion medicine and immunohaematology [thrombotic thrombocytopenic purpura (TTP), immune thrombocytopenia (ITP), warm autoimmune haemolytic anaemia (wAIHA), cold agglutinin disease (CAD)]
- Developing the evidence base for platelet transfusion and alternatives to transfusion
Key publications
-
Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial.
Journal article
Desborough MJR. et al, (2023), Lancet Neurol, 22, 557 - 567
-
Restrictive versus liberal blood transfusion for gastrointestinal bleeding: a systematic review and meta-analysis of randomised controlled trials.
Journal article
Odutayo A. et al, (2017), Lancet Gastroenterol Hepatol, 2, 354 - 360
-
Current practice and registration patterns among United Kingdom Haemophilia Centre Doctors' Organisation centers for patients with unclassified bleeding disorders.
Journal article
Thomas W. et al, (2021), J Thromb Haemost
-
Drug-induced thrombotic thrombocytopenic purpura: A systematic review and review of European and North American pharmacovigilance data.
Conference paper
Schofield J. et al, (2022), Br J Haematol
-
Real-World Evidence of Caplacizumab Use in the Management of Acute TTP.
Journal article
Dutt T. et al, (2020), Blood
Recent publications
-
Blood transfusion strategies for major bleeding in trauma.
Journal article
Brunskill SJ. et al, (2025), Cochrane Database Syst Rev, 4
-
Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial.
Journal article
TREATT Trial Investigators None., (2025), Lancet Haematol, 12, e14 - e22
-
Hypercoagulation after Hospital Discharge in Acute Severe Ulcerative Colitis: A Prospective Study.
Journal article
Griffiths BJ. et al, (2024), Clin Gastroenterol Hepatol
-
Myocardial iron intake following intravenous iron therapy with ferric carboxymaltose is sustained at 1 year despite recurrence of iron deficiency.
Journal article
Piechnik SK. et al, (2024), Br J Haematol
-
Transfusion Camp: The UK experience and its value in improving knowledge of transfusion medicine among postgraduate trainees.
Journal article
Aggarwal A. et al, (2024), Transfus Med
ORCID
0000-0002-1951-5616